Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/1999
08/12/1999WO1999040089A1 Benzothiadiazoles and derivatives
08/12/1999WO1999040085A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999WO1999040084A1 Salts of paroxetine
08/12/1999WO1999040080A1 Hydroxamic and carboxylic acid derivatives
08/12/1999WO1999040068A2 2-aminoquinoline derivatives having d4-agonistic activity
08/12/1999WO1999040067A2 Benzisoxazole derivatives having d4-antagonistic activity
08/12/1999WO1999039714A1 Remedies for neurological disorders
08/12/1999WO1999039712A1 Substituted semicarbazides and the use thereof
08/12/1999WO1999039710A1 Use of 2-amino-6- trifluoromehthoxy- benzothiazole for preventing or treating cerebellum dysfunction
08/12/1999WO1999039709A1 Liquid pharmaceutical formulation containing zotepine
08/12/1999WO1999039696A1 Propofol composition containing sulfite
08/12/1999WO1999031230A3 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof
08/12/1999WO1999028343A3 Hydrophobically-modified protein compositions and methods
08/12/1999WO1999027919A3 Cyp2a enzymes and their use in therapeutic and diagnostic methods
08/12/1999WO1999021875A9 Kcnq2 and kcnq3-potassium channel genes which are mutated in benign familial neonatal convulsions (bfnc) and other epilepsies
08/12/1999WO1999021574A9 Enhancement of morphogen activity
08/12/1999WO1999020291A9 Pharmaceutical grade ginkgo biloba
08/12/1999WO1999015684A8 Expression of genes in hematopoietic stem cells in hischaemic conditions
08/12/1999WO1999000116A3 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
08/12/1999WO1998048784A3 Method and composition for modulating amyloidosis
08/12/1999WO1996037199A8 Use of r-enantiomer of n-propargyl-1-aminoindan, salts, and compositions thereof
08/12/1999CA2321257A1 Remedies for neurological disorders
08/12/1999CA2321175A1 Method of screening therapeutic agents
08/12/1999CA2320490A1 Neuroprotective peptides and uses thereof
08/12/1999CA2320475A1 Liquid pharmaceutical formulation containing zotepine
08/12/1999CA2319652A1 Salts of paroxetine
08/12/1999CA2319484A1 Substituted semicarbazides and the use thereof
08/12/1999CA2319097A1 Dendritic enriched secreted lymphocyte activation molecule
08/12/1999CA2318977A1 Derivatives of benzoxadiazoles, benzothiadiazoles, benzotriazoles and quinoxalines
08/12/1999CA2317478A1 Benzofuran-4-carboxamides and their therapeutic use
08/12/1999CA2317476A1 Hydroxamic and carboxylic acid derivatives
08/11/1999EP0935000A2 Orphan receptor
08/11/1999EP0934937A1 Azole derivatives as superoxide radical inhibitor
08/11/1999EP0934934A2 Methods of preparing substituted 3-phenyl- and 3-pyridyl-4(3H)-quinazolinones and atropisomers thereof
08/11/1999EP0934931A2 3-Benzylidene-2-indolinones and their analogues as tyrosine kinase activity modulators
08/11/1999EP0934531A1 Diagnosis of spongiform encephalopathy
08/11/1999EP0934528A1 A method for the identification of compounds with anxiolytic potential
08/11/1999EP0934403A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
08/11/1999EP0934336A1 Novel compounds
08/11/1999EP0934335A1 Novel compounds
08/11/1999EP0934326A1 Substituted aminoalkane phosphonic acids
08/11/1999EP0934319A1 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS
08/11/1999EP0934314A1 N-substituted azaheterocyclic compounds
08/11/1999EP0934313A1 N-substituted azaheterocyclic compounds
08/11/1999EP0934312A1 1,4-disubstituted piperazines
08/11/1999EP0934311A2 New heterocyclylmethyl-substituted pyrazol derivates
08/11/1999EP0934308A1 3-pyridyloxymethyl heterocyclic ether compounds useful in controlling chemical synaptic transmission
08/11/1999EP0934307A1 Substituted azabicylic compounds and their use as inhibitors of the production of tnf and cyclic amp phosphodiesterase
08/11/1999EP0934306A1 N-substituted azaheterocyclic compounds
08/11/1999EP0934300A1 The preparation and use of ortho-sulfonamido heteroaryl hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999EP0934299A1 NOVEL $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/11/1999EP0934298A1 NOVEL (+)-ENANTIOMERS OF $i(CIS)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/11/1999EP0934297A1 NOVEL $i(cis)-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES
08/11/1999EP0934290A1 Aminothiazole derivatives, method of preparation and pharmaceutical compositions containing same
08/11/1999EP0934288A1 Oxadiazoles, processes for their preparation and their use as medicaments
08/11/1999EP0934287A1 Heterocyclic esters and amides
08/11/1999EP0934286A1 3-alkoxyisoxazol-4-yl-substituted 2-amino carboxylic acid compounds
08/11/1999EP0934282A1 1,4-benzodiazepinones and their uses as cck antagonists
08/11/1999EP0934281A1 1-phenyl-benzimidazole compounds and their use as baga- a? receptor modulators
08/11/1999EP0934273A1 New derivates from piperidine-keto acid, their preparation and use
08/11/1999EP0934271A1 Substituted arylalkylamines as neurokinin antagonists
08/11/1999EP0934264A1 Pyrrolidinyl and pyrrolinyl ethylamine compounds as kappa agonists
08/11/1999EP0934263A1 Heterocyclic thioesters and ketones
08/11/1999EP0934259A1 Beta-sulfonamido hydroxamic acids as matrix metalloproteinase and tace inhibitors
08/11/1999EP0934068A1 Compounds and methods
08/11/1999EP0934061A1 Isobutylgaba and its derivatives for the treatment of pain
08/11/1999EP0781282B1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINONE DERIVATIVES, THEIR PREPARATION AND USE
08/11/1999EP0756605B1 Peptides as therapeutic agents for the treatment of auto-immune diseases
08/11/1999EP0741724B1 Neuroprotective chroman compounds
08/11/1999EP0675717B1 Use of 2-amino-6-a-propylamino-4,5,6,7-tetrahydrobenzothiazole (pramipexol) as an anti-depressant drug
08/11/1999CN1225639A Phosphinate based inhibitors of matrix metalloproteases
08/11/1999CN1225637A Pyrrole triazines and pyrimidines
08/11/1999CN1225630A Methanesulphonate salt of an arylpiperzine derived from tryptamine and its solvates for pharmaceutical use
08/11/1999CN1225625A Alpha-amino acid amides, prepn. thereof and the therapeutic use thereof
08/11/1999CN1225623A Inhibition of matrix metalloproteases by acetylene contg. compounds
08/11/1999CN1225621A Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids
08/11/1999CN1225584A Tetrahydro-beta-carboline compounds
08/11/1999CN1225367A Bond partner, and use for sieving inhibitor and diagnosis and treatment of disease
08/11/1999CN1225362A Indole derivatives
08/10/1999US5936123 Compounds such as 3-isopropyl-4-hydrazinobenzoic acid and its salts
08/10/1999US5936088 Nervous system disorders
08/10/1999US5936084 Halo-substituted bisindolemaleimide protein kinase C inhibitors
08/10/1999US5936065 CS-1 peptidomimetics, compositions and methods of using the same
08/10/1999US5936000 Central nervous system disorders, e.g. schizophrenia, mania; antidepressants; drug abuse; parkinson's disease, anxiolytic agents; sleep and circadian rhythm disorders; senile dementia
08/10/1999US5935980 Use of pyrrolidine derivatives in the treatment of alcoholism
08/10/1999US5935974 Diphenylmethylene piperidine derivatives
08/10/1999US5935973 Affinity for 5-ht1a, alpha1, alpha2 and/or d2 receptors; antidepressants, anxiolytic agents, psychoses, dyskinesias, parkinson's disease, hypotensive agents, tourette's syndrome, obsessive-compulsive behaviour, panic attacks, social phobias
08/10/1999US5935972 Benzofuran derivatives as tachykinin antagonists
08/10/1999US5935970 Treatment of nerve system disorders, neurodegenerative diseases
08/10/1999US5935960 Treatment of schizophrenia
08/10/1999US5935953 Methods for controlling invertebrate pests using cocaine receptor binding ligands
08/10/1999US5935931 Human apoptosis-related calcium-binding protein
08/10/1999US5935927 Alzheimer*s disease, diabetes; removal amyloid from brain, pancreas
08/10/1999US5935865 Semaphorin gene family
08/10/1999US5935852 The present invention relates to a family of proteins designated as cerberus, which appears to be a pioneer protein, with a 9 cysteine residue pattern, which is present in the embryo.
08/10/1999US5935817 Genetic engineering
08/10/1999US5935814 G-protein coupled receptor family polypeptides, referred to as hfgan72y, altered nucleic acid seqences encoding it and recombinant materials and methods for its production; use in design of protocols and treatment of various infections
08/10/1999US5935795 Glial cell line-derived neurotrophic factor antibody
08/10/1999US5935781 Apolipoprotein E polymorphism and treatment of Alzheimer's disease
08/10/1999US5935565 Method for increasing the level of stem cells in peripheral blood
1 ... 1545 1546 1547 1548 1549 1550 1551 1552 1553 1554 1555 1556 1557 1558 1559 1560 1561 1562 1563 1564 1565 ... 1833